Vickers Vantage Corp. I also files under SCLX; those filings are included.
The public view is the crawlable proof. The same sourced dataset is available through REST and MCP for agents, research scripts, and back-office tools.
| Date | Insider | Role | Action | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Jul 3, 2026 | SCLX Stock Acquisition JV LLC | 10% Owner | Other(J) | 500K | — | — |
| Apr 17, 2026 | Ma Stephen Hoi | CFO, COO and Secretary, Director | Buy(P) | 650K | $0.15 | $100K |
| Apr 17, 2026 | Ji Henry | Exec Chair, CEO and President, Director | Sell(S) | 650K | $0.15 | $100K |
| Apr 16, 2026 | Ji Henry | Exec Chair, CEO and President, Director | Buy(P) | 3.3M | $0.15 | $500K |
| Dec 30, 2025 | Scilex Holding Co | 10% Owner | Sell(S) | 9.7M | $0.54 | $5.2M |
| Dec 29, 2025 | Scilex Holding Co | 10% Owner | Sell(S) | 7.3M | $0.66 | $4.8M |
| Dec 26, 2025 | Scilex Holding Co | 10% Owner | Sell(S) | 3.7M | $0.75 | $2.8M |
| Oct 8, 2025 | Chun Jay | Director | Grant(A) | 20K | — | $0 |
| Oct 8, 2025 | Ma Stephen Hoi | CFO and COO, Director | Grant(A) | 60K | — | $0 |
| Oct 8, 2025 | Wu Yue Alexander | Director | Grant(A) | 20K | — | $0 |
| Oct 8, 2025 | Followwill Dorman | Director | Grant(A) | 20K | — | $0 |
| Oct 8, 2025 | Ji Henry | CEO and President, Director | Grant(A) | 120K | — | $0 |
| Jan 21, 2025 | SCLX Stock Acquisition JV LLC | 10% Owner | Other(J) | 3.3M | — | — |
| Jan 16, 2025 | SCLX Stock Acquisition JV LLC | 10% Owner | Other(J) | 779K | — | — |
| Jan 2, 2025 | SCLX Stock Acquisition JV LLC | 10% Owner | Other(J) | 5.0M | — | — |
| Dec 18, 2024 | Shah Jaisim | See Remarks, Director | Buy(P) | 30K | $0.46 | $14K |
| Dec 16, 2024 | Followwill Dorman | Director | Grant(A) | 100K | — | $0 |
| Dec 16, 2024 | Wu Yue Alexander | Director | Grant(A) | 100K | — | $0 |
| Dec 16, 2024 | Chun Jay | Director | Grant(A) | 100K | — | $0 |
| Oct 31, 2024 | Ji Henry | Executive Chairperson, Director | Buy(P) | 9K | $0.94 | $8K |
| Oct 29, 2024 | Shah Jaisim | See Remarks, Director | Buy(P) | 32K | $0.99 | $32K |
| Oct 18, 2024 | Followwill Dorman | Director | Buy(P) | 1K | $0.99 | $990 |
| Oct 18, 2024 | Chun Jay | Director | Buy(P) | 5K | $0.95 | $5K |
| Oct 17, 2024 | Ji Henry | Executive Chairperson, Director | Buy(P) | 10K | $0.97 | $10K |
| Oct 17, 2024 | Wu Yue Alexander | Director | Buy(P) | 20K | $0.95 | $19K |
| Oct 17, 2024 | Lemus David | Director | Buy(P) | 2K | $0.90 | $2K |
| Oct 16, 2024 | Shah Jaisim | See Remarks, Director | Buy(P) | 30K | $0.99 | $30K |
| Oct 16, 2024 | Ma Stephen Hoi | Chief Financial Officer | Buy(P) | 7K | $0.97 | $6K |
| Aug 16, 2024 | Navani Annu | Director | Grant(A) | 250K | — | $0 |
| Jun 26, 2024 | Followwill Dorman | Director | Option exercise(M) | 1K | $1.37 | $1K |
| Jun 26, 2024 | Followwill Dorman | Director | Option exercise(M) | 1K | — | $0 |
| Jun 20, 2024 | Wu Yue Alexander | Director | Option exercise(M) | 5K | — | $0 |
| Jun 20, 2024 | Chun Jay | Director | Option exercise(M) | 5K | — | $0 |
| Jun 20, 2024 | Ma Stephen Hoi | Chief Financial Officer | Option exercise(M) | 2K | $1.41 | $3K |
| Jun 20, 2024 | Ma Stephen Hoi | Chief Financial Officer | Option exercise(M) | 2K | — | $0 |
| Jun 20, 2024 | Wu Yue Alexander | Director | Option exercise(M) | 5K | $1.41 | $7K |
| Jun 20, 2024 | Shah Jaisim | See Remarks, Director | Option exercise(M) | 14K | $1.73 | $24K |
| Jun 20, 2024 | Shah Jaisim | See Remarks, Director | Option exercise(M) | 14K | — | $0 |
| Jun 20, 2024 | Chun Jay | Director | Option exercise(M) | 5K | $1.41 | $7K |
| Jun 18, 2024 | Ji Henry | Executive Chairperson, Director | Option exercise(M) | 6K | $1.41 | $8K |
| Jun 18, 2024 | Ji Henry | Executive Chairperson, Director | Option exercise(M) | 6K | — | $0 |
| Jun 14, 2024 | Shah Jaisim | See Remarks, Director | Option exercise(M) | 33K | $1.41 | $47K |
| Jun 14, 2024 | Shah Jaisim | See Remarks, Director | Option exercise(M) | 33K | — | $0 |
| May 17, 2024 | Chun Jay | Director | Buy(P) | 58K | $0.90 | $52K |
| May 17, 2024 | Ma Stephen Hoi | Chief Financial Officer | Buy(P) | 14K | $0.88 | $12K |
| May 17, 2024 | Shah Jaisim | See Remarks, Director | Buy(P) | 57K | $0.92 | $52K |
| May 17, 2024 | Ji Henry | Executive Chairperson, Director | Buy(P) | 50K | $0.88 | $44K |
| May 16, 2024 | Shah Jaisim | See Remarks, Director | Buy(P) | 83K | $0.84 | $70K |
| Mar 15, 2024 | Followwill Dorman | Director | Grant(A) | 100K | — | $0 |
| Mar 15, 2024 | Lemus David | Director | Grant(A) | 100K | — | $0 |
| Oct 4, 2023 | Ji Henry | Executive Chairperson, Director | Grant(A) | 200K | — | $0 |
| Oct 4, 2023 | Chun Jay | Director | Grant(A) | 250K | — | $0 |
| Oct 4, 2023 | Wu Yue Alexander | Director | Grant(A) | 250K | — | $0 |
| Oct 4, 2023 | Shah Jaisim | See Remarks, Director | Grant(A) | 200K | — | $0 |
| Oct 4, 2023 | Ma Stephen Hoi | Chief Financial Officer | Grant(A) | 150K | — | $0 |
| Sep 21, 2023 | Sorrento Therapeutics, Inc. | 10% Owner | Sell(S) | 4.5M | — | — |
| Sep 21, 2023 | Sorrento Therapeutics, Inc. | 10% Owner | Sell(S) | 60.1M | — | — |
| Mar 17, 2023 | Ji Henry | Executive Chairperson, Director | Other(J) | 3K | $8.60 | $23K |
| Jan 19, 2023 | Sorrento Therapeutics, Inc. | 10% Owner | Other(J) | 73.7M | — | $0 |
| Jan 17, 2023 | Thompson Tommy G | Director | Grant(A) | 250K | — | $0 |
| Jan 17, 2023 | Followwill Dorman | Director | Grant(A) | 250K | — | $0 |
| Jan 17, 2023 | Czerepak Elizabeth | See Remarks | Grant(A) | 350K | — | $0 |
| Jan 17, 2023 | Lemus David | Director | Grant(A) | 250K | — | $0 |
| Jan 17, 2023 | Hamill Laura | Director | Grant(A) | 250K | — | $0 |
| Jan 17, 2023 | Lee Tien-Li | Director | Grant(A) | 250K | — | $0 |
| Jan 17, 2023 | Ji Henry | Executive Chairperson, Director | Grant(A) | 9.0M | — | $0 |
| Jan 17, 2023 | Shah Jaisim | See Remarks, Director | Grant(A) | 1.7M | — | $0 |
| Dec 2, 2022 | Sorrento Therapeutics, Inc. | 10% Owner | Buy(P) | 225K | $0.35 | $79K |
| Nov 25, 2022 | Sorrento Therapeutics, Inc. | 10% Owner | Buy(P) | 46K | $0.44 | $20K |
| Nov 23, 2022 | Sorrento Therapeutics, Inc. | 10% Owner | Buy(P) | 443K | $0.40 | $177K |
| Nov 22, 2022 | Sorrento Therapeutics, Inc. | 10% Owner | Buy(P) | 673K | $0.23 | $155K |
| Nov 10, 2022 | Ho Chris | Insider | Other(J) | 5.3M | — | — |
| Nov 10, 2022 | Sorrento Therapeutics, Inc. | 10% Owner | Other(J) | 307K | — | — |
| Nov 10, 2022 | Sorrento Therapeutics, Inc. | 10% Owner | Other(J) | 2.8M | — | — |
| Nov 10, 2022 | Ho Chris | Insider | Other(J) | 578K | — | — |
Insider transactions sourced from SEC EDGAR Form 4 filings, normalized within minutes of acceptance. "Buy"/"Sell" mark open-market transactions (codes P/S), the tradeable signal. Awards, option exercises and tax-withholding are shown with their raw code. All data is public domain.
Issuer: Vickers Vantage Corp. I, SEC CIK 0001820190. The symbol on a Form 4 is typed by the filer, so this page follows the issuer with the newest filing under VCKAU and shows every filing by that issuer (also filed as SCLX).
Coverage: Form 4 filings indexed 2006-01-02 → 2026-09-15. Earlier history is backfilling; this window widens as it deepens.
Programmatic access via the Arkolith API & MCP server (insider.transactions, insider.company).
Connected pages for VCKAU